CD8A and Miyoshi myopathy: In contrast, the routine-term hospitalization group demonstrated significant post-treatment increases in MM within the CD4+ Tn (P < 0.05), CD4+ Tcm (P < 0.05), CD8+ Tn (P < 0.001), CD8+ Tcm (P < 0.001), CD8+ Tef (P < 0.01), and CD8+ Tem (P < 0.01) subsets (Figure 5).